@RepNateMoran makes a great point: “Congress must continue to focus on policies that spur #pharmaceutical innovation at home beyond the immediate future because China has and will continue to outpace the U.S.” https://t.co/YRuUHYCjat
I, alongside my colleague @RepTerriSewell, are incredibly proud to announce President Trump has signed into law our bipartisan Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.
This critical law will give seniors access to groundbreaking innovation that will transform the way we treat, diagnose, and prevent cancer.
With over 338 House cosponsors, 60 Senate cosponsors, 500 supporting organizations, and even Dallas Cowboys QB @dak, together, we are unleashing the power of early detection and saving millions of lives.
Great News! Congress has passed the #MCEDAct! With this, the early detection of cancer will become a reality instead of simply a hope for millions of patients. Thank you, @RepArrington, @JohnCornyn, @RepVeasey!
More than 550 cancer advocacy organizations nationwide have highlighted the importance of the #MCEDAct. With tremendous bipartisan, bicameral backing, this legislation is ready to pass this January. @LeaderJohnThune@SenSchumer@SpeakerJohnson@RepJeffries Let’s get this done.
The #MCEDAct hit 400 cosponsors today!
As the most-supported bill in Congress, there's overwhelming bipartisan support to get this important legislation over the finish line. 💪
If passed, it could help innovative cancer #EarlyDetection tests reach more people who need them.
Cancer patients and families are counting on Congress to pass the #MCED Act this year. With 400 bipartisan members of Congress now backing this bill, it’s time to pass this lifesaving legislation, @RepArrington@JohnCornyn.
Thank you, @RepArrington, for your leadership on the #MCEDAct and your commitment to advancing early detection. Passing this important legislation will leave a lasting legacy in the fight against cancer.
Join BioNTX on June 25th as we welcome an Australian delegation to North Texas. Learn how a local successfully conducted trials in Australia and explore the advantages of this globally recognized, cost-effective clinical landscape.
Register now https://t.co/cdorgZIdoE
Congratulations to BioNTX members ClearSight Therapeutics and OncoSeer Diagnostics for joining the MassChallenge Healthcare cohort and pitching their innovations to top investors. We’re proud to support their work advancing global health.
TARSEC is hosting their next speaker and networking workshop on Wednesday, 4/16 in Fort Worth.
If you are interested in attending to share your views on the future of the Texas space economy, register using this link or by scanning the QR code below: https://t.co/qSWZo84j22
Join us on March 7th for BioNTX’s Women Driving Innovation program! Hear from women executives as they share their leadership journeys, strategies for success, and insights on fundraising and navigating biotech challenges.
Register now: https://t.co/mfyAsVeTJY
Join us March 7 for BioNTX’s Women Driving Innovation! Celebrate women shaping biotech in North Texas.
Join women scientists sharing groundbreaking research and impactful contributions in science, medicine, and entrepreneurship.
Register now: https://t.co/mfyAsVeTJY
Join us on March 7th for BioNTX’s Women Driving Innovation event, celebrating women in North Texas' biotech ecosystem. Hear from leaders transforming healthcare challenges into impactful innovations in women’s health.
Register now: https://t.co/mfyAsVeTJY
Per @GovWaste: “The #340B drug discount program is currently ripe for reform, and there is some hope that the 119th Congress could bring the program closer to its original intent.”
https://t.co/kwwIxLPww6
Join us on February 26th in Dallas for the BioNTX Legal Forum, sponsored by @SheppardMullin. Gain insights on PDUFA, small business exemptions & PDUFA VIII strategies. CLE credit available!
Register now! https://t.co/unBf4bDu7Y